Artículo
Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y)
Autor/es | García-Guerrero, Estefanía
Götz, Ralph Doose, Sören Sauer, Markus Rodríguez Gil, Alfonso Pérez Simón, José Antonio Danhof, Sophia |
Departamento | Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica |
Fecha de publicación | 2022 |
Fecha de depósito | 2022-12-15 |
Publicado en |
|
Cita | García-Guerrero, E., Götz, R., Doose, S., Sauer, M., Rodríguez Gil, A., Pérez Simón, J.A. y Danhof, S. (2022). Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y). Leukemia, 36 (1), 297. https://doi.org/10.1038/s41375-021-01355-6. |